Mechanism of arterial remodeling in chronic allograft vasculopathy

被引：18
作者：
Zheng Q. [1 ]
Liu S. [1 ]
Song Z. [1 ]
机构：
[1] Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
来源：
Frontiers of Medicine | 2011年 / 5卷 / 3期
基金：
中国国家自然科学基金;
关键词：
allograft vasculopathy; arterial remodeling; chronic rejection; immunology; neointimal; transplantation;
D O I：
10.1007/s11684-011-0149-3
中图分类号：
学科分类号：
摘要：
Chronic allograft vasculopathy (CAV) remains a major obstacle for long-term survival of grafts even though therapeutic strategies have improved considerably in recent years. CAV is characterized by concentric and diffuse neointimal formation, medial apoptosis, infiltration of lymphocyte or inflammatory cells, and deposition of extracellular matrix both in arteries and veins. Recent studies have shown that stem cells derived from the recipient contribute to neointimal formation under the regulation of chemokines and cytokines. Arterial remodeling in allografts eventually causes ischemic graft failure. The pathogenesis is multi-factorial with both immunologic and non-immunological factors being involved. The immunological factors have been discussed extensively in other articles. This review focuses mainly on the arterial remodeling that occurs in 3 layers of vessel walls including intimal injury, accumulation of smooth muscle-like cells in the neointimal, medial smooth muscle cell apoptosis, adventitial fibrosis, and deposition of extracellular matrix. © 2011 Higher Education Press and Springer-Verlag Berlin Heidelberg.
引用
收藏
页码：248 / 253
页数：5
相关论文
共 58 条
  • [1] Sayegh M.H., Carpenter C.B., Transplantation 50 years later-progress, challenges, and promises, N Engl J Med, 351, 26, pp. 2761-2766, (2004)
  • [2] Belperio J.A., Weigt S.S., Fishbein M.C., Lynch J.P., Chronic lung allograft rejection: mechanisms and therapy, Proc Am Thorac Soc, 6, 1, pp. 108-121, (2009)
  • [3] Hathout E., Beeson W.L., Kuhn M., Johnston J., Fitts J., Razzouk A., Bailey L., Chinnock R.E., Cardiac allograft vasculopathy in pediatric heart transplant recipients, Transpl Int, 19, 3, pp. 184-189, (2006)
  • [4] Religa P., Bojakowski K., Gaciong Z., Thyberg J., Hedin U., Arteriosclerosis in rat aortic allografts: dynamics of cell growth, apoptosis and expression of extracellular matrix proteins, Mol Cell Biochem, 249, 1-2, pp. 75-83, (2003)
  • [5] Yuan X., Paez-Cortez J., Schmitt-Knosalla I., D'Addio F., Mfarrej B., Donnarumma M., Habicht A., Clarkson M.R., Iacomini J., Glimcher L.H., Sayegh M.H., Ansari M.J., A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy, J Exp Med, 205, 13, pp. 3133-3144, (2008)
  • [6] Joosten S.A., van Kooten C., Paul L.C., Pathogenesis of chronic allograft rejection, Transpl Int, 16, 3, pp. 137-145, (2003)
  • [7] Hamano K., Bashuda H., Ito H., Shirasawa B., Okumura K., Esato K., Graft vasculopathy and tolerance: does the balance of Th cells contribute to graft vasculopathy?, J Surg Res, 93, 1, pp. 28-34, (2000)
  • [8] Rose M.L., Interferon-γ and intimal hyperplasia, Circ Res, 101, 6, pp. 542-544, (2007)
  • [9] Vessie E.L., Hirsch G.M., Lee T.D., Aortic allograft vasculopathy is mediated by CD8(+) T cells in Cyclosporin A immunosuppressed mice, Transpl Immunol, 15, 1, pp. 35-44, (2005)
  • [10] Wang C.Y., Aronson I., Takuma S., Homma S., Naka Y., Alshafie T., Brovkovych V., Malinski T., Oz M.C., Pinsky D.J., cAMP pulse during preservation inhibits the late development of cardiac isograft and allograft vasculopathy, Circ Res, 86, 9, pp. 982-988, (2000)
123456